VDR and neoplasm: VDR activation promotes the quiescent PSC state and inhibits tumor-supportive pathways.In allograft models, VD decreased stromal activation and fibrosis.In both mouse models, combination therapy reduced tumor volume, increased intratumoral vasculature and intratumoral concentration of gemcitabine, and survival was prolonged compared to gemcitabine alone.